Creative Biolabs-Immuno-oncology

Anti-CD5 (clone 4IC7J) SynExpress C-G-ER-X Modified CD8+ T cells (CAT#: ITS-1224-CR1660)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD5 (clone 4IC7J). We employs the pGEM (CMV-GFP-ER-XbaI) vector components and the SynExpress system of the Histone modification sites Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD5
Clone
4IC7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
ER
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Histone modification sites
Carrier Type
pGEM
Transformation Accuracy
0.92
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving